Startups

82VS Venture Partner

Alloy Therapeutics · Remote (US) · Remote

← All jobs
About Alloy Therapeutics

Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in antibodies and TCRs.

About the role

We are Alloy Therapeutics — a biotechnology ecosystem and Product Development Organization (PDO) empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • PhD, MD, or Masters with 5+ years experience in the fields of biomedical research, drug discovery or similar
  • Proven experience in venture creation or operational roles at early-stage venture backed start-ups. Prior experience in a Senior or C-suite role is highly desirable
  • Technical expertise in antibody and/or oligonucleotide drug discovery and development. Prior experience with antibody-oligo conjugates or ex-hepatic delivery is highly desirable
  • Experience supporting the advancement of therapeutic assets through discovery, pre-clinical, and/or clinical development in a scientific or operational role
  • Exceptional leadership, strategic planning, and decision-making skills. Strong business acumen and ability to manage complex transactions is desirable
  • Ability to work across various US and international time zones
More about this role

Role Location: Waltham, MA

The Company

We are Alloy Therapeutics — a biotechnology ecosystem and Product Development Organization (PDO) empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. The company facilitates affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. At Alloy, we believe our industry should compete on getting the best drugs to patients as quickly as possible, not exclusive access to the best platforms. As a reflection of our relentless commitment to the scientific community, we reinvest 100% of our revenue in innovation and access to innovation. May the Best Drug Win.

Alloy has evolved from a startup into a global product development organization operating 11 divisions across 5 research sites in 4 countries on 3 continents. Our model - Integrated Independence - combines centralized capabilities with entrepreneurial operating divisions....

Read the full posting on Alloy Therapeutics's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.